BioSpace News Archive

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of cannabis extractions and refined ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries is pleased to announce changes to its management structure following the recent granting of the Portugal R&D license.

Masimo announced that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers at Nippon Medical School in Tokyo, Japan used Masimo Patient SafetyNet™ and rainbow Acoustic Monitoring®, acoustic respiration rate monitoring with RRa®, as a centralized continuous monitoring system to identify the incidence and predictors of desaturation and bradypnea in postoperative patients

Inotrem S.A. announced it has initiated its Phase IIb ASTONISH trial to evaluate nangibotide in the treatment of septic shock and has enrolled the first patient in the trial.

SpendEdge, a global procurement market intelligence firm, has announced the release of its Global Pharmaceutical Drug Development Services Market - Procurement Intelligence Report.

Immune-Onc Therapeutics, Inc. is a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients.

Harpoon grants AbbVie option to license worldwide rights to HPN217 (BCMA), a TriTAC for the treatment of multiple myeloma planned for IND filing this year

AnaPath Services GmbH, the Swiss CRO specialized in histopathology, has acquired legacy Envigo CRS S.A.U. a CRO for non-clinical safety assessment on November 5th, 2019.

Boston IVF, the most experienced fertility provider in Massachusetts, offering world-renowned fertility treatment services, announced it has opened the doors of its new Worcester Fertility Center.

The award was announced on Nov. 21 at the inaugural STAT Summit, and celebrates one academic researcher who has had an enormous impact on the field of medicine.

Liam Kelly, President and CEO, Teleflex Incorporated, is scheduled to speak at the 31st Annual Piper Jaffray Healthcare Conference at The Lotte New York Palace Hotel, in New York City, on Thursday, December 5, 2019 at 9:00 a.m.